The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Open accessAbstract
The priming of tumor-antigen-specific T cells is critical for the initiation of successful anti-tumor immune responses, yet the fate of such cells during tumor progression is unknown. Naive CD4+T cells specific for an antigen expressed by tumor cells were transferred into tumor-bearing mice. Transient clonal expansion occurred early after transfer, accompanied by phenotypic changes associated with antigen recognition. Nevertheless, these cells had a diminished response to peptide antigen in vitro and were unable to be primed in vivo. The development of antigen-specific T cell anergy is an early event in the tumor-bearing host, and it suggests that tolerance to tumor antigens may impose a significant barrier to therapeutic vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Antigen-specific interaction between T and B cells
Lanzavecchia, A. (1985) · Nature · doi:10.1038/314537a0 · Cited by 1,412
The B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
Townsend, S. E., & Allison, J. P. (1993) · Science · doi:10.1126/science.7678351 · Cited by 1,136
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
Kearney, E. R., Pape, K. A., Loh, D. Y., & Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 946
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement
Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., & Abbas, A. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80284-8 · Cited by 716
North, R. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.4.1063 · Cited by 650
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., & Ochoa, A. C. (1992) · Science · doi:10.1126/science.1465616 · Cited by 632
B Cells Turn Off Virgin But Not Memory T Cells
Fuchs, E. J., & Matzinger, P. (1992) · Science · doi:10.1126/science.1439825 · Cited by 562
Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.
Eynon, E. E., & Parker, D. C. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.131 · Cited by 424
Kirberg, J., Baron, A., Jakob, S., Rolink, A., Karjalainen, K., & von Boehmer, H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.25 · Cited by 410
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke, J. H., Zea, A. H., Stanley, J., Longo, D., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O’Shea, J. J., Kudoh, S., & Klein, E. A. (1993) · PubMed · Cited by 379
CTLA-4: a negative regulator of autoimmune disease.
Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.783 · Cited by 376
Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J., Vivier, É., Anderson, P., & Kiessling, R. W. (1993) · PubMed · Cited by 339
Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Chused, T. M., & Schwartz, R. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5409 · Cited by 298
Self-citationBaskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., & Glimcher, L. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5687 · Cited by 263
Perrin, P. J., Maldonado, J. H., Davis, T. A., June, C. H., & Racke, M. K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1333 · Cited by 226
Schultze, J. L., Cardoso, A. A., Freeman, G. J., Seamon, M. J., Daley, J., Pinkus, G. S., Gribben, J. G., & Nadler, L. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8200 · Cited by 206
Ronchese, F., & Hausmann, B. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.679 · Cited by 206
Glimcher, L. H., Kim, K. J., Green, I., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.2.445 · Cited by 198
Can B cells turn on virgin T cells?
Lassila, O., Vainio, O., & Matzinger, P. (1988) · Nature · doi:10.1038/334253a0 · Cited by 185
The Yin and Yang of T Cell Costimulation
Allison, J. P., & Krummel, M. F. (1995) · Science · doi:10.1126/science.270.5238.932 · Cited by 180
Levitsky, H. I., Montgomery, J., Ahmadzadeh, M., Staveley-O’Carroll, K., Guarnieri, F., Longo, D. L., & Kwak, L. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3858 · Cited by 174
Self-citationBogen, B. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261119 · Cited by 161
Awwad, M., & North, R. J. (1989) · PubMed · Cited by 159
Alexander, J. P., Kudoh, S., Melsop, K. A., Hamilton, T. A., Edinger, M. G., Tubbs, R. R., Sica, D., Tuason, L. J., Klein, E. A., & Bukowski, R. M. (1993) · PubMed · Cited by 153
Conditions That Induce Tolerance in Mature CD4+ T Cells
Lanoue, A., Bona, C. A., von Boehmer, H., & Sarukhan, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.405 · Cited by 146
Tartour, É., Latour, S., Mathiot, C., Thiounn, N., Mosseri, V., Joyeux, I., d’Enghien, C. D., Lee, R., Debré, B., & Fridman, W. H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630210 · Cited by 104
Cited by
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Self-citationImmune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Metadata
- Authors
- Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-02-03
- Volume
- 95
- Issue
- 3
- Pages
- 1178-1183
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1987589866
- Cited by
- 704
- References
- 32
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.